We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Africa’s plan to manufacture at least 60% of its own vaccines to reduce dependence on imports has received a major boost after a financing initiative was launched to support investment in expanded vaccine production and supply within continent.